Pancreatic Cancer: Current Concepts, Trends, and Future Directions
Pancreatic ductal adenocarcinoma (PC) ranks among the deadliest cancers, with a less than 15% 5-year survival rate. Epidemiological studies project that it will become the second leading cause of cancer-associated mortalities in the following decades. The hallmarks of pancreatic cancer lead to tumor...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2025-02-01
|
| Series: | The Turkish Journal of Gastroenterology |
| Online Access: | https://www.turkjgastroenterol.org/en/pancreatic-cancer-current-concepts-trends-and-future-directions-137296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860485041160192 |
|---|---|
| author | Patrick Wenzel Carolin Mogler Kıvanç Görgülü Hana Algül |
| author_facet | Patrick Wenzel Carolin Mogler Kıvanç Görgülü Hana Algül |
| author_sort | Patrick Wenzel |
| collection | DOAJ |
| description | Pancreatic ductal adenocarcinoma (PC) ranks among the deadliest cancers, with a less than 15% 5-year survival rate. Epidemiological studies project that it will become the second leading cause of cancer-associated mortalities in the following decades. The hallmarks of pancreatic cancer lead to tumor aggressiveness and therapeutic resistance. For this reason, the field has been focusing on multiple dimensions to generate better therapeutic approaches, including new adjuvant, neoadjuvant, and palliative concepts to extend the survival of PC patients. Over the last 2 decades, clinical trials have significantly improved disease prognosis and patient survival. To achieve better outcomes and to deeply understand the therapeutic approaches, molecular tumor boards have become crucial for deeper exploitation of tumor genetics and tumor biology, providing better stratification markers for therapeutic regimens. Using recently developed targeted therapies, such as KRAS inhibitors, the field has gathered momentum and been tooled up with the help of new sequencing technologies. Therefore, researchers and clinicians have geared up for the battle against PC. This review will systematically discuss recent developments in adjuvant, neoadjuvant, and palliative treatment modalities. Moreover, the paradigm-shifting importance of genetic profiling on pancreatic cancer. will be explained through a showcase to frame future directions. |
| format | Article |
| id | doaj-art-3a0bd8b7a16a4f4295ca245420c7d518 |
| institution | Kabale University |
| issn | 2148-5607 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | AVES |
| record_format | Article |
| series | The Turkish Journal of Gastroenterology |
| spelling | doaj-art-3a0bd8b7a16a4f4295ca245420c7d5182025-02-10T12:58:10ZengAVESThe Turkish Journal of Gastroenterology2148-56072025-02-01362698110.5152/tjg.2024.24544Pancreatic Cancer: Current Concepts, Trends, and Future DirectionsPatrick Wenzel0https://orcid.org/0009-0003-9570-3576Carolin Mogler1https://orcid.org/0000-0003-3400-7254Kıvanç Görgülü2https://orcid.org/0000-0002-1613-1422Hana Algül3https://orcid.org/0000-0002-5067-7031Comprehensive Cancer Center Munich TUM, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany ; Internal Medicine II, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, GermanyComprehensive Cancer Center Munich TUM, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany ; Institute for Pathology, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, GermanyComprehensive Cancer Center Munich TUM, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany ; Institute for Tumor Metabolism, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, GermanyComprehensive Cancer Center Munich TUM, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany ; Institute for Tumor Metabolism, TUM University Hospital, Klinikum rechts der Isar, Technical University of Munich, Munich, GermanyPancreatic ductal adenocarcinoma (PC) ranks among the deadliest cancers, with a less than 15% 5-year survival rate. Epidemiological studies project that it will become the second leading cause of cancer-associated mortalities in the following decades. The hallmarks of pancreatic cancer lead to tumor aggressiveness and therapeutic resistance. For this reason, the field has been focusing on multiple dimensions to generate better therapeutic approaches, including new adjuvant, neoadjuvant, and palliative concepts to extend the survival of PC patients. Over the last 2 decades, clinical trials have significantly improved disease prognosis and patient survival. To achieve better outcomes and to deeply understand the therapeutic approaches, molecular tumor boards have become crucial for deeper exploitation of tumor genetics and tumor biology, providing better stratification markers for therapeutic regimens. Using recently developed targeted therapies, such as KRAS inhibitors, the field has gathered momentum and been tooled up with the help of new sequencing technologies. Therefore, researchers and clinicians have geared up for the battle against PC. This review will systematically discuss recent developments in adjuvant, neoadjuvant, and palliative treatment modalities. Moreover, the paradigm-shifting importance of genetic profiling on pancreatic cancer. will be explained through a showcase to frame future directions.https://www.turkjgastroenterol.org/en/pancreatic-cancer-current-concepts-trends-and-future-directions-137296 |
| spellingShingle | Patrick Wenzel Carolin Mogler Kıvanç Görgülü Hana Algül Pancreatic Cancer: Current Concepts, Trends, and Future Directions The Turkish Journal of Gastroenterology |
| title | Pancreatic Cancer: Current Concepts, Trends, and Future Directions |
| title_full | Pancreatic Cancer: Current Concepts, Trends, and Future Directions |
| title_fullStr | Pancreatic Cancer: Current Concepts, Trends, and Future Directions |
| title_full_unstemmed | Pancreatic Cancer: Current Concepts, Trends, and Future Directions |
| title_short | Pancreatic Cancer: Current Concepts, Trends, and Future Directions |
| title_sort | pancreatic cancer current concepts trends and future directions |
| url | https://www.turkjgastroenterol.org/en/pancreatic-cancer-current-concepts-trends-and-future-directions-137296 |
| work_keys_str_mv | AT patrickwenzel pancreaticcancercurrentconceptstrendsandfuturedirections AT carolinmogler pancreaticcancercurrentconceptstrendsandfuturedirections AT kıvancgorgulu pancreaticcancercurrentconceptstrendsandfuturedirections AT hanaalgul pancreaticcancercurrentconceptstrendsandfuturedirections |